Resultados da pesquisa - M. Sebag

Random error propagation on electron beam dynamics for a 50 MeV S-band linac Por H Purwar, E Goutierre, H Guler, M Rossetti Conti, S Chance, A Gonnin, H Monard, A Bacci, M Sebag, J Cohen, C Bruni

Obter o texto integral

P897: UPDATED RESULTS FROM THE ONGOING PHASE 1 STUDY OF ELRANATAMAB, A BCMA TARGETED T-CELL REDIRECTING IMMUNOTHERAPY, FOR PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA Por A. Dalovisio, N. Bahlis, N. Raje, C. Costello, B. Dholaria, M. Solh, M. Levy, M. Tomasson, H. Dube, M. Damore, S. Jiang, C. Basu, A. Skoura, E. Chan, S. Trudel, A. Jakubowiak, M. Chu, C. Gasparetto, M. Sebag, A. Lesokhin

Obter o texto integral

Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma... Por A. Visram, A. De La Torre, D. White, J. Su, E. Masih-Khan, M. Chu, V. Jimenez-Zepeda, A. McCurdy, R. LeBlanc, K. Song, H. Mian, M. Louzada, M. Sebag, D. Bergstrom, J. Stakiw, A. Reiman, R. Kotb, M. Aslam, C. Venner, R. Kaedbey, E. Gul, D. Reece

Obter o texto integral

P38 | SAFETY AND EFFICACY OF TALQUETAMAB + TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM PHASE 1b OF REDIRECTT-1: RESULTS WITH AN EXTENDED MEDIAN FOLLOW-U... Por E.M. Ocio, M-V. Mateos, H. Magen, M. Gatt, M. Sebag, K. Kim, C-K. Min, S-S. Yoon, M.P. Chu, P. Rodríguez-Otero, I. Avivi, N.A. Quijano Cardé, M. Krevvata, T. Henninger, P. Thakkar, M. Festa, L. Huang, J.X. Zhou, M. Takamoto, L. Pei, J. Lu, C. Maffucci, E. Scott, A. Oriol, D. Morillo, Y.C. Cohen

Obter o texto integral